About Triptorelin Acetate
            
            Class: | Gonadotropin-releasing hormone (GnRH) agonist  
Use: | Treatment of hormone-sensitive conditions such as prostate cancer, endometriosis, precocious puberty, and as part of assisted reproductive technology protocols  
Adult dose: | Typically, 3.75 mg (1 mL of 105 mcg/mL solution) administered intramuscularly once every 28 days for prostate cancer; dosing may vary based on specific condition  
Pediatric dose: | For precocious puberty, 0.1 mg/kg body weight administered intramuscularly eve
         
        
            
                
                
                    
                        Drug Class
                    
                    Gonadotropin-releasing hormone (GnRH) agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of hormone-sensitive conditions such as prostate cancer, endometriosis, precocious puberty, and as part of assisted reproductive technology protocols
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; once reconstituted, use immediately or store in the refrigerator for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Ferring GmbH, GERMANY
                    
                    
                    Package Size
                    1ml Pre-filled Syringe x 7
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 282.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Typically, 3.75 mg (1 mL of 105 mcg/mL solution) administered intramuscularly once every 28 days for prostate cancer; dosing may vary based on specific condition
                    
                    
                        Pediatric Dose
                    
                    
                        For precocious puberty, 0.1 mg/kg body weight administered intramuscularly every 4 weeks, not to exceed 3.75 mg per dose
                    
                 
                
                
                    
                        Side Effects
                    
                    Hot flashes, injection site reactions, headache, mood changes, decreased libido, fatigue, nausea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to triptorelin or any component of the formulation; pregnancy; breastfeeding; certain hormone-sensitive tumors
         
        
        
            
                Important Warnings
            
            Risk of tumor flare in patients with prostate cancer; may cause significant hormonal changes; monitor for signs of adrenal insufficiency; use caution in patients with a history of seizures or cardiovascular disease
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.